This prospective clinical trial compares drug eluding stents to drug coated stents in peripheral vascular diseases of the lower extremity.
This endovascular treatment for the thoracic aorta provides a less invasive option for diseases of the descending thoracic aorta. This treament is available for aneurysms and all Type B dissections.
Intermacs is a North American registry for the clinical outcomes of patients who receive an FDA-approved mechanical circulatory support device to treat advanced heart failure.
This registry is a collaboration between the Society for Thoracic Surgeons and the ACC and monitors patient safety and real-world outcomes related to transcatheter valve replacement and repair procedures – emerging treatments for valve disease patients. Employing state-of-the-art heart valve technology, transcatheter heart valve procedures provide new treatment options for…
This is the first national registry capturing data on left atrial appendage occlusion procedures to assess real-world procedural outcomes, short and long-term safety, comparative effectiveness, and cost-effectiveness.
This is a nationwide quality program that helps participating hospitals to measure and improve care for patients receiving implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices with defibrillator (CRT-Ds).
The purpose of this registry is to assess the characteristics, treatments and outcomes of cardiac disease patients who receive diagnostic catheterization and/or percutaneous coronary intervention (PCI) procedures. This powerful tool captures the data that measure adherence to ACC/AHA clinical practice guideline recommendations, procedure performance standards and appropriate use criteria for…
This is a non-randomized registry that will retrospectively enroll subjects who participated in the S-ICD Clinical Investigation (IDE G090013) and prospectively enroll new candidates for the S-ICD System.
The purpose of this study is to identify a series of genetic markers and biomarkers that specifically predict risk of arrhythmic death as compared to other causes of mortality among CAD patients.
This is a prospective, multi-center, randomized, controlled clinical study, designed to evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve and Delivery Systems (PORTICO) via transfemoral and alternative delivery methods. This trial includes both high-risk and extreme-risk patients.